减重手术对瑞典肥胖受试者研究痛风发病率的影响:非随机前瞻性对照干预试验
基于瑞典肥胖受试者(SOS)研究的非随机前瞻性对照干预试验,纳入1982例接受减重手术者和1999例肥胖对照,基线均无痛风。中位随访约19年,减重手术与痛风发病率降低相关(校正HR 0.60,95%CI 0.48-0.75,p<0.001),并与高尿酸血症发病率降低相关(校正HR 0.47,95%CI 0.39-0.58,p<0.001)。
要点
- 减重手术与痛风发病率降低独立相关,校正HR 0.60(95%CI 0.48-0.75,p<0.001)。
- 减重手术与高尿酸血症发病率降低相关,校正HR 0.47(95%CI 0.39-0.58,p<0.001)。
- 15年绝对风险差:痛风3个百分点,高尿酸血症12个百分点。
核心结论
- 减重手术可预防肥胖受试者的痛风和高尿酸血症。
- 减重手术与痛风发病率降低相关(校正HR 0.60,95%CI 0.48-0.75,p<0.001)。
- 减重手术与高尿酸血症发病率降低相关(校正HR 0.47,95%CI 0.39-0.58,p<0.001)。
研究设计与样本
- 瑞典肥胖受试者(SOS)研究为前瞻性干预试验,比较减重手术与常规治疗。
- 本报告纳入1982例接受减重手术者和1999例肥胖对照,基线均无痛风。
- 痛风发病终点基于国家登记和问卷中的痛风诊断及降尿酸药物使用信息。
- 痛风发病率中位随访约19年;高尿酸血症在基线尿酸<6.8 mg/dL亚组中随访至多20年。
主要发现
- 减重手术与痛风发病率降低相关(校正HR 0.60,95%CI 0.48-0.75,p<0.001)。
- 15年时组间痛风绝对风险差为3个百分点;预防1例痛风需治疗32例(95%CI 22-59)。
- 减重手术对痛风发病率的影响不受包括体重指数在内的基线危险因素影响。
- 减重手术与高尿酸血症发病率降低相关(校正HR 0.47,95%CI 0.39-0.58,p<0.001)。
- 15年时组间高尿酸血症绝对风险差为12个百分点;预防1例高尿酸血症需治疗8例(95%CI 6-13)。
关键数值与推荐
- 痛风发病终点定义基于痛风诊断和痛风药物使用信息(来自国家登记和问卷)。
- 高尿酸血症分析限于基线尿酸<6.8 mg/dL的亚组参与者。
- 痛风发病率中位随访约19年;高尿酸血症随访至多20年。
临床怎么用
- 对肥胖且无痛风人群,减重手术可能降低长期痛风及高尿酸血症发病风险。
- 减重手术对痛风的预防效果不受基线体重指数等危险因素影响。
- 临床决策可结合15年绝对风险差(痛风3个百分点、高尿酸血症12个百分点)及需治疗人数评估。
局限性
- 本研究为非随机对照干预试验,非随机设计可能引入混杂。
- 痛风发病终点基于登记和问卷信息,非统一临床确诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the long-term effect of bariatric surgery on the incidence of gout and hyperuricaemia in participants of the Swedish Obese Subjects (SOS) study. METHODS: This report includes 1982 subjects who underwent bariatric surgery and 1999 obese controls from the SOS study, a prospective intervention trial designed to assess the effect of bariatric surgery compared with conventional treatment. None of the subjects had gout at baseline. An endpoint on gout incidence was created based on information on gout diagnosis and use of gout medications through national registers and questionnaires. Median follow-up for the incidence of gout was about 19 years for both groups. Moreover, the incidence of hyperuricaemia over up to 20 years was examined in a subgroup of participants having baseline uric acid levels <6.8 mg/dL. RESULTS: Bariatric surgery was associated with a reduced incidence of gout compared with usual care (adjusted HR 0.60, 95% CI 0.48 to 0.75, p<0.001). The difference in absolute risk between groups was 3 percentage points at 15 years, and the number of subjects needed to be treated by bariatric surgery to prevent one incident gout event was 32 (95% CI 22 to 59). The effect of bariatric surgery on gout incidence was not influenced by baseline risk factors, including body mass index. During follow-up, the surgery group had a lower incidence of hyperuricaemia (adjusted HR 0.47, 95% CI 0.39 to 0.58, p<0.001). The difference in absolute risk between groups was 12 percentage points at 15 years, and the number of participants needed to be treated by bariatric surgery to prevent hyperuricaemia was 8 (95% CI 6 to 13). CONCLUSIONS: Bariatric surgery prevents gout and hyperuricaemia in obese subjects. TRIAL REGISTRATION NUMBER: NCT01479452; Results.
引用
- Maglio C, Peltonen M, Neovius M, et al. Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial. Ann Rheum Dis. 2016. PMID: 28076240. doi:10.1136/annrheumdis-2016-209958
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。